Article
20 Oct 2026
GLOBE Most Favored Nations Drug Pricing Model For Medicare Part B Drugs Finalized And Scaled Down By CMS
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
06 Jan 2026
Health Headlines: December 2025
Article
29 Dec 2025
CMS Releases MFN Drug Pricing Models For Medicare Parts B And D And Medicaid Amid Trump Administration's Push For Direct-to-Consumer Strategy
Article
03 Oct 2025
Life Sciences And Medtech Policy Update: Key Things To Know Q4 2025
Article
04 Apr 2025
A Look Ahead In Life Sciences: What We Are Tracking In The Second Quarter Of 2025 And Beyond
Article
13 Mar 2025
US Emerging As Top Global Medtech Destination
Article
03 Oct 2024
A Look Ahead In Life Sciences: What We Are Tracking In The Fourth Quarter Of 2024 And Beyond
Article
26 Apr 2024
The European Parliament Adopts Position On The European Commission's Proposal For The First Major Overhaul Of The EU Medicines Regulatory Framework In 20 Years
Article
05 Apr 2024
A Look Ahead In Life Sciences: What We Are Tracking In Q2 2024 And Beyond
Article
09 Jan 2024
A Look Ahead In Life Sciences: What We Are Tracking In Q1 2024 And Beyond
Article
18 Sep 2023
UK's Medicines Regulator Announces Guidance On The New International Recognition Procedure For The Approval Of New Medicines From 1 January 2024
Article
03 Jul 2023
The European Commission Proposes First Major Overhaul Of The EU Medicines Regulatory Framework In 20 Years: Orphan Medicines
Article
24 May 2023
The European Commission Proposes First Major Overhaul Of The EU Medicines Regulatory Framework In 20 Years: Regulatory Data Protection
Article
04 May 2023
The MHRA Proposes To Extend The Period Of Acceptance Of CE Marked Medical Devices In Great Britain Beyond 30 June 2023
Article
01 May 2023
The European Commission Proposes First Major Overhaul Of The EU Medicines Regulatory Framework In 20 Years
Article
10 Jan 2023
The European Commission Proposes To Extend The Transition Deadline In The EU Medical Device Regulation